Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05455424
Title Niraparib Efficacy in Patient With Unresectable Mesothelioma (NERO)
Acronym NERO
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Hospital Southampton NHS Foundation Trust
Indications
Therapies
Age Groups: senior | adult
Covered Countries GBR

Facility Status City State Zip Country Details
University Hospital Southampton, Southampton General Hospital Southampton Hampshire SO16 6YD United Kingdom Details
Medway NHS Foundation Trust, Medway Maritime Hospital Gillingham Kent ME7 5NY United Kingdom Details
Somerset NHS Foundation Trust, Musgrove Park Hospital Taunton Somerset TA1 5DA United Kingdom Details
Belfast Health and Social Care Trust, Belfast City Hospital Belfast BT9 7AB United Kingdom Details
Velindre University NHS Trust, Velindre Cancer Centre Cardiff CF15 7QZ United Kingdom Details
Beatson West of Scotland Cancer Centre Glasgow G12 0YN United Kingdom Details
The Princess Alexandra Hospital NHS Trust, The Princess Alexandra Hospital Harlow CM20 1QX United Kingdom Details
Hull University Teaching Hospitals NHS Trust, Castle Hill Hospital Hull HU16 5JQ United Kingdom Details
Leeds Teaching Hospitals NHS Trust, St James's Hospital Leeds LS9 7TF United Kingdom Details
University Hospitals of Leicester NHS Trust, Royal Leicester Infirmary Leicester LE2 7LX United Kingdom Details
Sheffield Teaching Hospitals NHS Foundation Trust, Weston Park Hospital Sheffield S10 2JF United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field